YARW
Yarrow Bioscience, Inc.
+2.63 (+10.14%)28.57USD106K成交股數76.3M市值10.5本益比(近四季)158.3股價營收比+40.6%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 97K-52% | 86K+2% | 215K+78% | 69K-65% | 202K+106% | 84K-26% | 121K-10% | 198K+100% | 98K | 114K | 135K | 99K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 788K | 817K | −1.5M | 4.9M | 6.1M | 9.7M | 10.2M | 7.3M | 3.7M | 3.3M | 7.2M | 2.7M |
| 銷售管理費用 | 2.4M | 3.1M | 1.9M | 2.7M | 3.3M | 3.2M | 3.0M | 3.3M | 3.8M | 3.0M | 3.2M | 3.2M |
| 營業利益 | −3.1M-66% | −3.8M-70% | −240K-98% | −7.5M-27% | −9.2M+25% | −12.8M+105% | −13.1M+27% | −10.4M+77% | −7.4M | −6.2M | −10.3M | −5.9M |
| 營業利益率 | -3,197.9% | -4,437.2% | -111.6% | -10,930.4% | -4,553.0% | -15,202.4% | -10,819.0% | -5,250.5% | -7,530.6% | -5,468.4% | -7,643.0% | -5,934.3% |
| 稅後淨利 | −3.0M-65% | −3.6M-70% | −95K-99% | −5.8M-39% | −8.6M+38% | −12.0M+83% | −12.2M+21% | −9.4M+67% | −6.2M | −6.6M | −10.1M | −5.6M |
| 淨利率 | -3,100.0% | -4,168.6% | -44.2% | -8,340.6% | -4,262.9% | -14,311.9% | -10,047.1% | -4,750.5% | -6,376.5% | -5,775.4% | -7,450.4% | -5,678.8% |
| 稀釋 EPS | -3.51+1655% | -0.08-70% | 6.58-2369% | -6.73+2959% | -0.20+33% | -0.27-87% | -0.29-91% | -0.22-87% | -0.15 | -2.01 | -3.09 | -1.74 |
| 稀釋股數 | 858K | 42.8K | 42.8M | 855K | 42.7K | 42.6M | 42.6M | 42.6M | 42.6M | 3.3M | 3.3M | 3.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 22.9M | 24.6M | 24.0M | 22.0M | 28.2M | 19.9M | 16.3M | 29.6M | 19.1M | 15.4M | 20.6M | 30.2M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | 250K | 234K | 105K |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 23.6M | 25.9M | 30.2M | 44.7M | 56.4M | 66.9M | 76.2M | 86.6M | 91.7M | 19.3M | 25.0M | 35.3M |
| 有息負債 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 總負債 | 1.5M | 1.2M | 2.4M | 5.8M | 12.3M | 14.8M | 12.7M | 11.8M | 8.3M | 7.8M | 7.7M | 8.8M |
| 股東權益 | 22.1M | 24.6M | 27.8M | 38.9M | 44.1M | 52.1M | 63.5M | 74.9M | 83.4M | 11.5M | 17.3M | 26.4M |
| 負債比 | 6.5% | 4.8% | 7.9% | 13.1% | 21.8% | 22.1% | 16.6% | 13.6% | 9.1% | 40.3% | 30.8% | 25.0% |
| 淨現金(現金 − 有息負債) | 22.9M | 24.6M | 24.0M | 22.0M | 28.2M | 19.9M | 16.3M | 29.6M | 19.1M | 15.4M | 20.6M | 30.2M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −4.1M | – | – | −11.5M+44% | – | – | – | −8.0M | – | – | −5.5M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | 6K | – | – | 6K | – | – | – | 0.00 | – | – | 0.00 |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2022 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2022 年度 · 477K
| Royalty | 477K | 100.0% | -48.8% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 570K | +13.8% | −26.5M | -4,646.1% | -0.62 | −33.1M |
| FY2024 | 501K | +18.2% | −39.8M | -7,950.9% | -0.93 | −34.1M |
| FY2023 | 424K | -11.1% | −28.5M | -6,710.4% | -2.78 | −25.3M |
| FY2022 | 477K | -48.8% | −23.2M | -4,865.8% | -7.28 | – |
| FY2021 | 931K | -95.6% | −73.3M | -7,876.4% | -25.64 | −56.4M |
| FY2020 | 21.0M | +4638.8% | −256M | -1,217.4% | 7.88 | −137M |
| FY2019 | 443K | -87.7% | −95.2M | -21,484.9% | 11.22 | −74.5M |
| FY2018 | 3.6M | – | −74.2M | -2,062.9% | 11.47 | −69.2M |